The Pennant Group, Inc. (NASDAQ:PNTG) Holdings Lifted by Cubist Systematic Strategies LLC

Cubist Systematic Strategies LLC boosted its position in shares of The Pennant Group, Inc. (NASDAQ:PNTG) by 210.7% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 31,887 shares of the company’s stock after buying an additional 21,624 shares during the quarter. Cubist Systematic Strategies LLC’s holdings in The Pennant Group were worth $846,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of the company. Balyasny Asset Management L.P. boosted its stake in The Pennant Group by 42.3% during the fourth quarter. Balyasny Asset Management L.P. now owns 22,638 shares of the company’s stock valued at $600,000 after buying an additional 6,733 shares in the last quarter. Bank of America Corp DE boosted its stake in The Pennant Group by 94.0% during the fourth quarter. Bank of America Corp DE now owns 122,340 shares of the company’s stock valued at $3,244,000 after buying an additional 59,286 shares in the last quarter. BNP Paribas Financial Markets bought a new position in The Pennant Group during the fourth quarter valued at about $2,022,000. Algert Global LLC boosted its stake in The Pennant Group by 10.2% during the fourth quarter. Algert Global LLC now owns 97,551 shares of the company’s stock valued at $2,587,000 after buying an additional 9,049 shares in the last quarter. Finally, Freestone Grove Partners LP purchased a new stake in shares of The Pennant Group during the fourth quarter valued at $305,000. Institutional investors own 85.88% of the company’s stock.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on PNTG. Stephens reaffirmed an “overweight” rating and set a $38.00 target price on shares of The Pennant Group in a report on Wednesday, April 2nd. Truist Financial upped their target price on The Pennant Group from $28.00 to $32.00 and gave the company a “hold” rating in a report on Monday. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat, The Pennant Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $35.60.

The Pennant Group Trading Up 0.5%

Shares of NASDAQ PNTG opened at $29.31 on Thursday. The company has a market cap of $1.01 billion, a price-to-earnings ratio of 43.10, a P/E/G ratio of 2.24 and a beta of 1.56. The Pennant Group, Inc. has a 12 month low of $21.18 and a 12 month high of $37.13. The company has a quick ratio of 1.12, a current ratio of 1.12 and a debt-to-equity ratio of 0.58. The business has a fifty day simple moving average of $25.42 and a 200-day simple moving average of $27.32.

The Pennant Group Company Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.